UK enacts law to decentralise manufacture of personalised treatments
The UK Government has passed legislation to decentralise the manufacture of personalised medicines, allowing them to be prepared in facilities…
All articles by Abigail Beaney
Abigail Beaney
Abigail Beaney is the editor of Clinical Trials Arena. Abigail has expertise in clinical trial regulation, trial design, outsourcing, and cell and gene therapies. Abigail also has covered news and has a wealth of knowledge across several therapy areas including neurodegenerative, infectious and metabolic diseases. Abigail holds a first-class BA (Hons) degree in Journalism from the University of Central Lancashire in the United Kingdom. She has also obtained the National Qualification in Journalism through the UK's media industry body, the National Council for the Training of Journalists. Contact Abigail
-
-
Protecting patients’ data is vital for NHS single health record system
Experts are emphasising that safeguarding patient data from corporations and cyberattacks is vital for the NHS to create a single…
-
Wes Streeting: £29bn NHS boost ‘substantial’ but reform still needed
A £29bn investment into the National Health System (NHS) is ‘substantial’, but reform of the system is essential to ‘fix…
-
US Elections: how healthcare could look under a Harris or Trump administration
With less than three weeks before Americans head to the polls, the election race is heating up. It is still…
-
How will a Labour government support the UK clinical trials industry?
On 4 July 2024, the people of the UK took to the polls and made their voice heard, voting for…
-
NHS boss praises managers and leaders as Tories seek to scrap £1bn funding
The chief executive of the National Health Service (NHS) England spoke about her desire to ‘bolster management and leadership’ after…
-
NHS investment critical to drive cell and gene therapy research
In May 2023, former health minister Lord James O’Shaughnessy acknowledged in a report that there were many issues with the…
-
Bucking the trend: How the UK can replicate the Greater Manchester model
At a time when commercial clinical trial patient recruitment has substantially declined in the UK, one borough completely bucked the…
